Four in Five Eligible Cancer Patients Lack Biomarker Testing: Lancet Commission

About four in five cancer patients globally who require biomarker testing do not receive the testing needed to guide their diagnosis or treatment, a new Lancet Oncology Commission publication has found. The publication, unveiled on Friday at the World Cancer Congress in Hong Kong, estimates that between seven million and eight million cancer patients […] The post Four in Five Eligible Cancer Patients Lack Biomarker Testing: Lancet Commission appeared first on SummitPost News .